HomeBUSINESS
BUSINESS

Chordia President Confident in Success of “Synthetic Lethality” Drug; Negotiated Directly with Takeda to Establish Startup
(Dec.7.2017)

Chordia President Hiroshi Miyake
Hiroshi Miyake, president of Chordia Therapeutics, a biotech company established by a group of former researchers of Takeda Pharmaceutical, recently sat with Jiho to talk about the background of the establishment of the company. “I think Takeda gave our startup the go sign because it felt we could maximize the value of its development pipeline,” said Mr Miyake who served as head of the oncology drug discovery unit at Takeda’s Shonan Research Center, indicating that the two parties share mutual interests ...
(LOG IN FOR FULL STORY)